The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection
Open accessAbstract
in certain patients.Because of this error, an increase in the albumin-to-creatinine ratio was not reported for some patients.Table 3, which has been corrected at NEJM.org, now has slightly smaller sample sizes than those shown in the original version of the table .Patients who had only one follow-up visit were included in the original table.By definition, these patients could not have had progression, since an elevated albumin-tocreatinine ratio for 2 successive years was required to show progression.Both progression from normal to either microalbuminuria or macroalbuminuria (P = 0.03) and progression from either normal or microalbuminuria to macroalbuminuria (P = 0.04) favor intensive treatment.Any progression of albuminuria is now highly statistically significant (P<0.01);13.8% of the patients in the standard-therapy group, as compared with 9.1% of patients in the intensivetherapy group, had worsening albuminuria.We appreciate the opportunity to update our results regarding nephropathy, but we regret any confusion this may cause.The rest of Table 3 remains unaffected.As a consequence of these changes in Table 3, parts of the Abstract, Results, and Discussion are affected (see the correction notice in this issue of the Journal), but the overall conclusions of the trial are similar.We regret these errors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
Kamar, N., Selves, J., Mansuy, J.-M., Ouezzani, L., Péron, J.-M., Guitard, J., Cointault, O., Esposito, L., Abravanel, F., Danjoux, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706992 · Cited by 1,350
Hepatitis E: an emerging infection in developed countries
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70255-x · Cited by 669
Self-citationThe role of hepatitis E virus testing in drug‐induced liver injury
DALTON, H. R., FELLOWS, H. J., STABLEFORTH, W., JOSEPH, M., THURAIRAJAH, P. H., WARSHOW, U., HAZELDINE, S., REMNARACE, R., IJAZ, S., HUSSAINI, S. H., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03504.x · Cited by 219
Self-citation
Cited by
Zhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61030-6 · Cited by 803
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
Rein, D. B., Stevens, G. A., Theaker, J., Wittenborn, J. S., & Wiersma, S. T. (2012) · Hepatology · doi:10.1002/hep.25505 · Cited by 739
Kamar, N., Dalton, H. R., Abravanel, F., & Izopet, J. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-13 · Cited by 675
Self-citationEASL Clinical Practice Guidelines on hepatitis E virus infection
Dalton, H. R., Kamar, N., Baylis, S. A., Moradpour, D., Wedemeyer, H., & Negro, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.005 · Cited by 665
Self-citationRibavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Kamar, N., Izopet, J., Tripon, S., Bismuth, M., Hillaire, S., Dumortier, J., Radenne, S., Coilly, A., Garrigue, V., D'Alteroche, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1215246 · Cited by 520
Hoofnagle, J. H., Nelson, K. E., & Purcell, R. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204512 · Cited by 479
Long-Term Efficacy of a Hepatitis E Vaccine
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406011 · Cited by 378
Hepatitis E virus: advances and challenges
Nimgaonkar, I., Ding, Q., Schwartz, R. E., & Ploss, A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.150 · Cited by 352
Pathogenesis and Treatment of Hepatitis E Virus Infection
Wedemeyer, H., Pischke, S., & Manns, M. P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.014 · Cited by 336
Shukla, P., Nguyen, H. T., Torian, U., Engle, R. E., Faulk, K., Dalton, H. R., Bendall, R. P., Keane, F. E., Purcell, R. H., & Emerson, S. U. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018878108 · Cited by 326
Self-citationShukla, P., Nguyen, H. T., Faulk, K., Mather, K., Torian, U., Engle, R. E., & Emerson, S. U. (2012) · Journal of Virology · doi:10.1128/jvi.00146-12 · Cited by 279
Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses
Yin, X., Ambardekar, C., Lu, Y., & Feng, Z. (2016) · Journal of Virology · doi:10.1128/jvi.02804-15 · Cited by 275
Drexler, J. F., Seelen, A., Corman, V. M., Fumie Tateno, A., Cottontail, V., Melim Zerbinati, R., Gloza-Rausch, F., Klose, S. M., Adu-Sarkodie, Y., Oppong, S. K., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00800-12 · Cited by 267
Low prevalence of hepatitis E in Iceland: a seroepidemiological study
Löve, A., Björnsdottir, T. B., Olafsson, S., & Björnsson, E. S. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1420218 · Cited by 15
Metadata
- Authors
- Dalton, H. R., Bendall, R. P., Keane, F. E., Tedder, R. S., & Ijaz, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-09-03
- Volume
- 361
- Issue
- 10
- Pages
- 1025-1027
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2019629311
- Cited by
- 547
- References
- 3
- FWCI
- 21.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.